Paul Farr

Verified

Member, Anthos Management GP at Anthos CapitalListed on SEC Form ADVSanta Monica, United States

Claim this profile

Cold

Check Size

Not yet known

Reliability Score

🎯100% of deals in Healthcare

Investment Timeline

Cambrian BioPharma

Board seat (SEC Form D)Source

Since Jan 2025

Company last raised Jul 2026

Portfolio Breakdown

By Sector

Healthcare1 deal · 100%

By Stage

1 tracked deal1 sector · 0 stages

Deal Velocity

Avg Deals / Year

1.0

Avg Deal Size

Unknown

Largest Deal

Cambrian BioPharma

Unknown

YoY Trend

Steady

Deals Per Year

1 total deal tracked2025–2025

Investment Activity Map

Jan

Feb

Mar

Apr

May

Jun

Jul

Aug

Sep

Oct

Nov

Dec

2025

Less

Current Fund Status

Fund Name

Anthos Capital II, L.P.

Reported Size

$30.9M

Co-Investors

No co-investment data available yet.